Thomas Mooe

9.3k citations
83 papers · 7.2k · 5 hit papers · h-index 28

Impact in

Papers in

    • Acute Myocardial Infarction Research 21
    • Antiplatelet Therapy and Cardiovascular Diseases 15
    • Cardiac Health and Mental Health 7
    • Blood Pressure and Hypertension Studies 4
    • Acute Ischemic Stroke Management 20

Thomas Mooe

83 papers receiving 6.7k citations

Thomas Mooe's Hit Papers

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study 2022 · 249 citations
2490+3+6Years since publication5001k1.5k2k

Peers

Thomas Mooe
Comparison fields: 5 of 101
  • Endocrinology, Diabetes and Metabolism 2.2k
  • Cardiology and Cardiovascular Medicine 1.8k
  • Physiology 1.3k
  • Nephrology 465
  • Internal Medicine 127
Replace Kelley R. Branch with:
Kelley R. Branch United States
Ilkka M Kantola Finland
Kunihiko Matsui Japan
Tami L. Bair United States
Stuart R. Warren United States
Jean‐Pierre Cambou France
Carlos Alberto Cuneo Canada
Eve Gillespie United Kingdom
Serge Kownator France
Patrick Henry France
Thomas Mooe relative to Kelley R. Branch United States Kelley R. Branch's profile →
Citations per field
00.5×2×4×6×8×9.6×
Kelley R. Branch · 1×
Citations per year

Countries citing papers authored by Thomas Mooe

Since Specialization
Citations

This map shows the geographic impact of Thomas Mooe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Mooe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Mooe more than expected).

Fields of papers citing papers by Thomas Mooe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Mooe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Mooe. The network helps show where Thomas Mooe may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas Mooe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Mooe Line = papers co-authored together Thomas Mooe links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Hit paper breakdown →
20192345
2
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
Hit paper breakdown →
2017679
3
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
Hit paper breakdown →
2017608
4
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Hit paper breakdown →
2019498
5 2001329
6 1996272
7
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
Hit paper breakdown →
2022249
8 2008202
9
Sleep-disordered breathing: a novel predictor of atrial fibrillation after coronary artery bypass surgery.
1996171
10 1996136
11 2000130
12 1996126
13 2022123
14 199792
15 202191
16 202079
17 201771
18 199966
19 201456
20 200749

About Thomas Mooe

Thomas Mooe is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology, Physiology, Public Health, Environmental and Occupational Health and Neurology, having authored 83 papers that have together received 7.2k indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (21 papers), Acute Ischemic Stroke Management (20 papers), Antiplatelet Therapy and Cardiovascular Diseases (15 papers), Obstructive Sleep Apnea Research (8 papers), Cardiac Health and Mental Health (7 papers), Health Promotion and Cardiovascular Prevention (5 papers), Telemedicine and Telehealth Implementation (5 papers) and Blood Pressure and Hypertension Studies (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.2k citations), Cardiology and Cardiovascular Medicine (1.8k citations), Physiology (1.3k citations), Nephrology (465 citations) and Internal Medicine (127 citations). Thomas Mooe has collaborated with scholars based in Sweden, Australia and Iran. Frequent co-authors include Terje Rabben, Urban Wiklund, Karl A. Franklin, Peter Eriksson, Karin Holmström, Lars Söderström, Birgitta Stegmayr, Per Olof Eriksson, Anders Ulvenstam and Hans C. Stenlund. Their work appears in journals such as Stroke, Scientific Reports, PLoS ONE, The Lancet and BMC Cardiovascular Disorders.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact